1-3 of 3
Sung Ho Park
Close
Sort by
Journal Articles

Improvement of Treatment-Free Remission Rate Following Discontinuation of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Phase, Chronic Myeloid Leukemia

Sewon Lee, Hongtae Kim, Semin Lee, Seunghoon Kim, Sung-Ho Park, Sung-Hyun Kim, Young Rok Do, Soo-Hyun Kim, Kyung-Mi Kee, Dong-Wook Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 1806.
https://doi.org/10.1182/blood-2023-178408
Published: 2023
Journal Articles

G-749, a novel FLT3 kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemia

Hee Kyu Lee, Hong Woo Kim, In Yong Lee, Jungmi Lee, Jaekyoo Lee, Dong Sik Jung, Sang Yeop Lee, Sung Ho Park, Haejun Hwang, Jang-Sik Choi, Jung-Ho Kim, Se Won Kim, Jung Keun Kim, Jan Cools, Jong Sung Koh, Ho-Juhn Song
Journal: Blood
Blood (2014) 123 (14): 2209–2219.
https://doi.org/10.1182/blood-2013-04-493916
Published: 2014
Includes: Supplemental data
Journal Articles

Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody

Cheolho Cheong, Jae-Hoon Choi, Laura Vitale, Li-Zhen He, Christine Trumpfheller, Leonia Bozzacco, Yoonkyung Do, Godwin Nchinda, Sung Ho Park, Durga Bhavani Dandamudi, Elina Shrestha, Maggi Pack, Han-Woong Lee, Tibor Keler, Ralph M. Steinman, Chae Gyu Park
Journal: Blood
Blood (2010) 116 (19): 3828–3838.
https://doi.org/10.1182/blood-2010-06-288068
Published: 2010